Gland Pharma Limited (GLAND.NS) - Winst- en verliesrekening per kwartaal

Home
GLAND.NS
Financiële Gegevens

1777.6 (INR) • At close November 8, 2024

Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) INR.

	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1	2019 Q4	2019 Q3	2019 Q1
Omzet Numbers are in millions	14,058.33	14,017.1	15,374.5	15,451.55	13,734.24	12,086.93	7,850.11	9,382.88	10,444.04	8,568.98	10,864.51	10,633.25	10,804.69	11,539	8,485.09	8,594.19	8,315	8,631.84	5,737.78	6,459.35	6,609
Kosten van de omzet Numbers are in millions	10,444.74	10,582.64	11,014.79	5,992.39	5,215.64	4,529.03	3,648.41	4,270.69	5,194.63	3,740.54	5,452.92	5,034.24	5,240.08	5,364.93	3,915.51	4,068.68	3,735.03	3,199.52	2,555.49	2,774.33	2,721.56
Brutowinst Numbers are in millions	3,613.59	3,434.46	4,359.71	9,459.16	8,518.6	7,557.9	4,201.7	5,112.19	5,249.41	4,828.44	5,411.59	5,599.01	5,564.61	6,174.07	4,569.58	4,525.51	4,579.97	5,432.32	3,182.29	3,685.02	3,887.44
Brutowinstmarge Numbers are in millions	0.257	0.245	0.284	0.612	0.62	0.625	0.535	0.545	0.503	0.563	0.498	0.527	0.515	0.535	0.539	0.527	0.551	0.629	0.555	0.57	0.588
Onderzoek- en ontwikkelingskosten Numbers are in millions	493	489	436	530	351	457	678	512	414	410	559	699	578	438	304	434	0	67.62	173	312	52.34
Algemene en administratieve kosten Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	29.35	0	0	34.42
Verkoop- en marketingkosten Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	91.66	0	0	33.67
Verkoop-, algemene en administratieve kosten Numbers are in millions	1,088.28	1,221.11	1,263.29	1,271.61	1,294.47	2,550.04	516.19	401	533.28	980.01	957.06	814.32	823.18	345.23	405.7	821.67	785.58	121.01	695.79	672.12	68.09
Overige kosten Numbers are in millions	0	514.26	421.47	373.91	531.55	375.42	389.39	615.09	656.24	743.91	-1,571.05	456.69	511.97	618.38	-792.85	351.3	203.52	28.66	-919.89	252.88	1.93
Bedrijfskosten Numbers are in millions	1,581.28	1,710.11	1,699.29	6,948.68	6,090.81	5,271.51	2,892.94	2,592.58	2,647.62	2,478.33	2,233.56	2,388.23	2,059.79	2,064.04	1,539.32	2,132.84	1,849.6	1,546.93	1,008.28	1,809.62	1,479.28
Bedrijfsresultaat Numbers are in millions	2,032.31	1,724.35	2,660.42	2,884.39	2,959.34	2,286.39	1,133.54	3,134.7	3,258.03	2,350.11	3,174.61	3,210.78	3,504.92	4,110.03	3,030.26	2,392.67	2,933.89	3,885.39	2,174.01	1,875.4	2,408.16
Bedrijfsresultaat ratio Numbers are in millions	0.145	0.123	0.173	0.187	0.215	0.189	0.144	0.334	0.312	0.274	0.292	0.302	0.324	0.356	0.357	0.278	0.353	0.45	0.379	0.29	0.364
Totaal overige inkomsten en kosten netto Numbers are in millions	535.47	458.1	321.89	-52.81	-60.46	326.27	-22.03	-26.2	-17.21	734.88	630.23	444.85	501.73	608.37	459.17	339.71	-7.6	314.61	441.11	196.1	335.1
Inkomen voor belasting Numbers are in millions	2,567.78	2,182.45	2,982.31	2,831.58	2,898.88	2,612.66	1,111.51	3,108.5	3,240.82	3,084.99	3,804.84	3,655.63	4,006.65	4,718.4	3,489.43	2,732.38	2,926.29	4,200	2,615.12	2,071.5	2,743.26
Inkomen voor belasting ratio Numbers are in millions	0.183	0.156	0.194	0.183	0.211	0.216	0.142	0.331	0.31	0.36	0.35	0.344	0.371	0.409	0.411	0.318	0.352	0.487	0.456	0.321	0.415
Belastingkosten Numbers are in millions	932.46	744.84	1,058.1	913.02	958.06	671.64	324.68	789.01	828.4	793.3	945.82	925.34	985.84	1,211.88	885.34	691.31	737.72	1,064.1	667.19	530.51	905.52
Nettowinst Numbers are in millions	1,635.32	1,437.61	1,924.2	1,918.56	1,940.82	1,941.02	786.83	2,319.49	2,412.42	2,291.69	2,859.02	2,730.29	3,020.81	3,506.52	2,604.09	2,041.07	2,188.57	3,135.9	1,947.93	1,540.99	1,837.74
Nettowinstmarge Numbers are in millions	0.116	0.103	0.125	0.124	0.141	0.161	0.1	0.247	0.231	0.267	0.263	0.257	0.28	0.304	0.307	0.237	0.263	0.363	0.339	0.239	0.278
WPA (Winst Per Aandeel) Numbers are in millions	9.93	8.73	11.68	11.65	11.78	11.79	4.78	14.08	14.65	13.93	17.4	16.62	18.37	21.41	16.37	12.83	13.4	19.21	11.93	9.44	11.25
Verwaterde WPA Numbers are in millions	9.93	8.73	11.68	11.65	11.78	11.78	4.78	14.08	14.65	13.92	17.24	16.62	18.37	21.37	16.37	12.82	13.4	19.21	11.93	9.44	11.25
EBITDA Numbers are in millions	3,567.16	2,643.97	3,586.5	3,937.81	3,772.34	3,314.96	1,508.96	3,510.81	3,624.75	3,443.13	4,117.52	3,945.81	4,277.99	4,981.18	3,743.86	2,993.62	3,180.52	4,447.13	2,851.33	2,370.59	2,792.23
EBITDA ratio Numbers are in millions	0.254	0.189	0.233	0.255	0.275	0.274	0.192	0.374	0.347	0.402	0.379	0.371	0.396	0.432	0.441	0.348	0.383	0.515	0.497	0.367	0.422

Gland Pharma Limited

NSE:GLAND.NS Add to watchlist

NSE:GLAND.NS